Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas

Acta Oto-Laryngologica, Supplement

Volumn , Issue 538, 1998, Pages 254-260

  Sakamoto, Hirokazu ^a   Nakai, Yoshiaki ^a   Ohashi, Yoshihiro ^a   Matsuda, Miki ^a   Sakashita, Tetushi ^a   Nasako, Yoshiro ^a   Kitayama, Hayato ^a   Kawabe, Joji ^a   Okamura, Terue ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 18F 2 deoxy D glucose (FDG) scans; Head and neck tumor; Positron emission tomography (PET); Radiation therapy

Indexed keywords

CARBOPLATIN; DEOXYGLUCOSE; FLUORINE 18; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RADIATION DOSE; RADIOACTIVITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; SCINTISCANNING;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031593537     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and the anesthetized albino rat. J Neurochem 1977; 28: 897-916.
2. 18F] 2-fluoro-2-deoxy-D-glucosevalidation of method. Ann Neurol 1979; 6: 371-88.
3. Warburg O. On the origins of cancer cells. Science 1956; 123: 309-14.
4. 18F] fluorodeoxy-glucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-71.
5. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 31: 1927-33.
6. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-48.
7. Haberkorn U, Straus LG, Reisser CH, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of flow cytometry. J Nucl Med 1991; 32: 1548-55.
8. Ito K, Kato T, Tadokoro M, et al. Recurrent renal cancer and scar differential with PET and MR imaging. Radiology 1992; 182: 549-53.
9. Sakamoto H, Nakai Y, Ohashi Y, Okamura T, Ochi H. Positron emission tomographic imaging of head and neck lesions. Eur Arch Otorhinolaryngol 1997; 254 (Suppl 1): 123-6.
10. Reisser C, Haberkorn U, Strauss LG. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 1993; 22: 231-8.
11. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck PET imaging with 2-[F-18]fluoro-2-deoxy-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
12. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of head and neck: quantitation with PET. Radiology 1993; 189: 807-12.
13. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastasis of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211-6.
14. McGuirt WF, Greven KM, Keyes Jr JW, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 1995; 104: 274-8.
15. McGuirt WF, Keyes Jr JW, Greven KM, et al. Preoperative identification of benign versus malignant parotid masses: a comparative study including positron emission tomography. Laryngoscope 1995; 105: 579-84.
16. Greven KM, Williams III DW, Keyes Jr JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74: 1355-9.
17. Reisser C, Haberkorn U, Strass AD, et al. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head Neck Surg 1995; 121: 272-6.
18. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Org 1990; 24: 606-9.
19. Calvert AH, Newell DR, Gumbrelly LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on real function. J Clin Oncol 1989; 7: 1748-56.
20. Shimosato Y, Oboshi S, Baba K. Histological evaluation of effect of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1971; 1: 19-35.
21. 3H]thymidine, and gallium-67. J Nucl Med 1991; 32: 2118-23.